Pharma News | GPAT DISCUSSION CENTER - Part 18

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection
- February 27, 2020
- Posted By : admin
- 0 Comment
APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and
Read More
AstraZeneca divests global rights to Movantik; License to RedHill Biopharma
- February 27, 2020
- Posted By : admin
- 0 Comment
AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill).
Read More
Sanofi teams up with U.S. agency against coronavirus
- February 19, 2020
- Posted By : Peeyush Jaiswal
- 0 Comment
French drugmaker Sanofi is working with a U.S. government agency to develop a vaccine against the new coronavirus from China,
Read More
WuXi Vaccines signs 20-year vaccine manufacturing contract
- February 19, 2020
- Posted By : Peeyush Jaiswal
- 0 Comment
WuXi Vaccines (Hong Kong) Ltd. said it has partnered with an undisclosed global company and signed a 20-year vaccine manufacturing
Read More
Ascletis’ IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
- February 19, 2020
- Posted By : Peeyush Jaiswal
- 0 Comment
Ascletis Pharma Inc. (HKEX code: 1672) announces today the application for in-house developed Category 1 Drug ASC41 for clinical trials
Read More

17
18
19

Offers